These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 1742721)

  • 1. Hair loss associated with fluoxetine treatment.
    Ananth J; Elmishaugh A
    Can J Psychiatry; 1991 Oct; 36(8):621. PubMed ID: 1742721
    [No Abstract]   [Full Text] [Related]  

  • 2. Severe hair loss associated with fluoxetine use.
    Jenike MA
    Am J Psychiatry; 1991 Mar; 148(3):392. PubMed ID: 1992847
    [No Abstract]   [Full Text] [Related]  

  • 3. The benefits of clomipramine-fluoxetine combination in obsessive compulsive disorder.
    Browne M; Horn E; Jones TT
    Can J Psychiatry; 1993 May; 38(4):242-3. PubMed ID: 8518974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluoxetine in obsessive compulsive disorder in adolescents.
    Bouvard M; Dugas M
    Int Clin Psychopharmacol; 1993; 8(4):307-10. PubMed ID: 8277152
    [No Abstract]   [Full Text] [Related]  

  • 5. Fluoxetine and memory impairment.
    Bradley SJ; Kulik L
    J Am Acad Child Adolesc Psychiatry; 1993 Sep; 32(5):1078-9. PubMed ID: 8407756
    [No Abstract]   [Full Text] [Related]  

  • 6. Fluoxetine treatment of obsessive-compulsive disorder: an open clinical trial.
    Liebowitz MR; Hollander E; Schneier F; Campeas R; Hatterer J; Papp L; Fairbanks J; Sandberg D; Davies S; Stein M
    J Clin Psychopharmacol; 1989 Dec; 9(6):423-7. PubMed ID: 2687337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluoxetine and schizophrenia in a patient with obsessional thinking.
    Baker RW
    J Neuropsychiatry Clin Neurosci; 1992; 4(2):232-3. PubMed ID: 1627986
    [No Abstract]   [Full Text] [Related]  

  • 8. Paradoxical reaction to buspirone augmentation of fluoxetine.
    Tanquary J; Masand P
    J Clin Psychopharmacol; 1990 Oct; 10(5):377. PubMed ID: 2258456
    [No Abstract]   [Full Text] [Related]  

  • 9. Fluoxetine-induced mania in a patient with obsessive-compulsive disorder.
    Steiner W
    Am J Psychiatry; 1991 Oct; 148(10):1403-4. PubMed ID: 1897626
    [No Abstract]   [Full Text] [Related]  

  • 10. Fluoxetine and suicidal ideation.
    Koizumi H
    J Am Acad Child Adolesc Psychiatry; 1991 Jul; 30(4):695. PubMed ID: 1890110
    [No Abstract]   [Full Text] [Related]  

  • 11. Fluoxetine and neuroleptic synergistic effects.
    Matthews P; Quinn D; Marcoux GS; Falkenberg K
    J Am Acad Child Adolesc Psychiatry; 1991 Jan; 30(1):154-5. PubMed ID: 2005055
    [No Abstract]   [Full Text] [Related]  

  • 12. Lithium augmentation of fluoxetine in the treatment of OCD and major depression: a case report.
    Howland RH
    Can J Psychiatry; 1991 Mar; 36(2):154-5. PubMed ID: 1904303
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pharmacotoxic psychosis and extrapyramidal motor syndrome. A case of acute adverse effect of fluoxetine and flupenthixol].
    Pach J
    Nervenarzt; 1992 Sep; 63(9):575-6. PubMed ID: 1407229
    [No Abstract]   [Full Text] [Related]  

  • 14. An open clinical trial of fluoxetine in the treatment of obsessive-compulsive disorder.
    Fontaine R; Chouinard G
    J Clin Psychopharmacol; 1986 Apr; 6(2):98-101. PubMed ID: 3517083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Re: Bradycardia and somnolence after adding fluoxetine to pimozide regimen.
    Friedman EH
    Can J Psychiatry; 1994 Dec; 39(10):634. PubMed ID: 7828116
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term fluoxetine treatment of a large number of obsessive-compulsive patients.
    Levine R; Hoffman JS; Knepple ED; Kenin M
    J Clin Psychopharmacol; 1989 Aug; 9(4):281-3. PubMed ID: 2504781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluoxetine for obsessive fear of loss of control of malodorous flatulence.
    Fishbain DA; Goldberg M
    Psychosomatics; 1991; 32(1):105-7. PubMed ID: 2003129
    [No Abstract]   [Full Text] [Related]  

  • 18. [Drug treatment of obsessive-compulsive disorders--a comparative study of the effectiveness of clomipramine and fluoxetine].
    Volk S
    Fortschr Neurol Psychiatr; 1995 Jun; 63 Suppl 1():28-32. PubMed ID: 7635392
    [No Abstract]   [Full Text] [Related]  

  • 19. Are fluoxetine plasma levels related to outcome in obsessive-compulsive disorder?
    Koran LM; Cain JW; Dominguez RA; Rush AJ; Thiemann S
    Am J Psychiatry; 1996 Nov; 153(11):1450-4. PubMed ID: 8890679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of adolescent obsessive-compulsive disorder with a clomipramine-fluoxetine combination.
    Simeon JG; Thatte S; Wiggins D
    Psychopharmacol Bull; 1990; 26(3):285-90. PubMed ID: 2274627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.